Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Recruiting · NCT07151378 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease | Disruptive, Impulse Control, and Conduct Disorders, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Phase 3 | 2026-07-13 | NCT07151378 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital Tuebingen | 123 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre for Neurology, Department forNeurodegenerative Disease, and Hertie-Institute forClinical Brain Research | Tübingen | Germany | 1 |
| Charité Campus Mitte | Berlin | Germany | 1 |
| DRK gemeinnützige Krankenhausgesellschaft mbH Saarland | Saarlouis | Germany | 1 |
| Knappschaft Kliniken Bottrop GmbH | Bottrop | Germany | 1 |
| Parkinson-Klinik Ortenau GmbH & Co. KG | Wolfach | Germany | 1 |
| Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR | Dresden | Germany | 4 |
| University Hospital Marburg | Marburg | Germany | 3 |